Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Head & Neck 1Gastrointestinal 1CNS 1Breast 1

Conditions

Thyroid Diseases 1Stomach Neoplasms 1Sarcoma 1Pancreatic Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Brain Neoplasms 1Adenolymphoma 1

Interventions

Magnetic Resonance Spectroscopy 270Specimen Handling 259pembrolizumab 235Cyclophosphamide 220Radiotherapy 208Nivolumab 171Cisplatin 162Carboplatin 150Biopsy 148Radiosurgery 130fludarabine 125Blood Specimen Collection 117Gemcitabine 113Paclitaxel 111Surveys and Questionnaires 109Standard of Care 106venetoclax 97Dexamethasone 96Bevacizumab 95Radiation 88Rituximab 84Capecitabine 82Cytarabine 79Oxaliplatin 77Doxorubicin 76Drug Therapy 75durvalumab 73Ipilimumab 72fludarabine phosphate 69atezolizumab 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Fluorescein × 90 days × Clear all
NCT03823144 2026-06-02

Intravital Microscopy in Human Solid Tumors

Mayo Clinic

Phase NA Recruiting
85 enrolled
BreastCNSGastrointestinalSarcoma

Brain Neoplasms, Breast Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06054178 2026-05-20

Identification of Nerves Using Fluorescein Sodium

Stanford University

Phase 2 Completed
8 enrolled 9 charts
Head & NeckLymphoid

Adenolymphoma, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡